Terminated NA INTERVENTIONAL 2-arm NCT02859493

Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

Evaluation of the Effect of Saccharomyces Cerevisiae on the Improvement of the Conventional Treatment for Vulvo-vaginal Infection to Candida Spp (Local Administration)

Sponsor: Lesaffre International

Conditions Candidiasis, Vulvovaginal

Interventions Placebo Saccharomyces cerevisiae

Updated 6 times since 2017 Last updated: Jun 11, 2018 Started: Aug 31, 2016 Primary completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment difficulties

A NA clinical study on Candidiasis, Vulvovaginal, this trial is terminated or withdrawn. The trial is conducted by Lesaffre International and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jul 2018 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jun 2018 — Jul 2018 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lesaffre International

Data source: Lesaffre International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villeurbanne, France